CSIMarket
 


4d Pharma Plc  (LBPS)
Other Ticker:  
 

Cumulative 4d Pharma Plc's Quick Ratio for Trailing Twelve Months Period

LBPS's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LBPS Quick Ratio for Trailing Twelve Months Period

(Dec 31 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Current Liabilities Growth - - - - -
Y / Y Cash & cash equivalent Growth - - - - -
Quick Ratio for Trailing Twelve Months Period 3.17 3.17 3.17 3.17 -
Total Ranking # 1286 # # # #
Seq. Current Liabilities Growth 0 % 0 % 0 % - -
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % - -


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2021
On the trailing twelve months basis Despite unchange in Current Liabilities in the IV. Quarter to $7 millions, average cumulative Quick Ratio for Trailing Twelve Months Period remained unchanged at 3.17 below 4d Pharma Plc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 396 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than 4d Pharma Plc. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about LBPS
Quick Ratio LBPS in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 397
Sector # 691
S&P 500 # 1259


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.17 3.17 3.17
(Dec 31 2021)  




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2021, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Aeterna Zentaris Inc   8.71 
Dermata Therapeutics Inc   8.63 
Advaxis Inc   8.48 
Gt Biopharma Inc   8.38 
Larimar Therapeutics Inc   8.34 
Sio Gene Therapies Inc   8.34 
Landos Biopharma Inc   8.21 
Catalyst Pharmaceuticals Inc   8.20 
Immunic Inc   8.14 
Schrodinger Inc   8.13 
Ampio Pharmaceuticals inc   8.10 
Geovax Labs Inc   8.10 
Immunome Inc  8.07 
Durect Corp  7.91 
Ngm Biopharmaceuticals Inc   7.90 
Liquidia Corporation  7.86 
Indaptus Therapeutics Inc   7.80 
Chinook Therapeutics Inc   7.79 
Protagonist Therapeutics inc   7.77 
Nektar Therapeutics  7.72 
Verastem inc   7.72 
Arvinas Inc   7.63 
Marinus Pharmaceuticals Inc   7.63 
Maravai Lifesciences Holdings Inc   7.60 
Imunon Inc   7.59 
Kadmon holdings inc   7.52 
Ocular Therapeutix Inc   7.44 
Opiant Pharmaceuticals Inc   7.43 
Phathom Pharmaceuticals Inc   7.37 
Lipocine Inc   7.37 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com